212 related articles for article (PubMed ID: 17767979)
1. Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels.
Sidló Z; Reggio PH; Rice ME
Neurochem Int; 2008 Jan; 52(1-2):80-8. PubMed ID: 17767979
[TBL] [Abstract][Full Text] [Related]
2. Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release.
Avshalumov MV; Rice ME
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11729-34. PubMed ID: 13679582
[TBL] [Abstract][Full Text] [Related]
3. Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion.
Bao L; Avshalumov MV; Rice ME
J Neurosci; 2005 Oct; 25(43):10029-40. PubMed ID: 16251452
[TBL] [Abstract][Full Text] [Related]
4. Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.
Avshalumov MV; Chen BT; Marshall SP; Peña DM; Rice ME
J Neurosci; 2003 Apr; 23(7):2744-50. PubMed ID: 12684460
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Nigrostriatal Dopamine Release by Striatal GABA
Lopes EF; Roberts BM; Siddorn RE; Clements MA; Cragg SJ
J Neurosci; 2019 Feb; 39(6):1058-1065. PubMed ID: 30541909
[TBL] [Abstract][Full Text] [Related]
6. Subsecond regulation of striatal dopamine release by pre-synaptic KATP channels.
Patel JC; Witkovsky P; Coetzee WA; Rice ME
J Neurochem; 2011 Sep; 118(5):721-36. PubMed ID: 21689107
[TBL] [Abstract][Full Text] [Related]
7. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area.
Chen BT; Rice ME
J Neurochem; 2002 Apr; 81(1):158-69. PubMed ID: 12067228
[TBL] [Abstract][Full Text] [Related]
8. AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release.
Avshalumov MV; Patel JC; Rice ME
J Neurophysiol; 2008 Sep; 100(3):1590-601. PubMed ID: 18632893
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Optically and Electrically Evoked Dopamine Release in Striatal Slices from Digenic Knock-in Mice with DAT-Driven Expression of Channelrhodopsin.
O'Neill B; Patel JC; Rice ME
ACS Chem Neurosci; 2017 Feb; 8(2):310-319. PubMed ID: 28177213
[TBL] [Abstract][Full Text] [Related]
10. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
Chen BT; Moran KA; Avshalumov MV; Rice ME
J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.
Han X; Liang Y; Hempel B; Jordan CJ; Shen H; Bi GH; Li J; Xi ZX
J Neurosci; 2023 Jan; 43(3):373-385. PubMed ID: 36517243
[TBL] [Abstract][Full Text] [Related]
13. Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.
Patel JC; Rice ME
ACS Chem Neurosci; 2012 Dec; 3(12):991-1001. PubMed ID: 23259034
[TBL] [Abstract][Full Text] [Related]
14. CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum.
Price DA; Owens WA; Gould GG; Frazer A; Roberts JL; Daws LC; Giuffrida A
J Neurochem; 2007 Apr; 101(2):389-96. PubMed ID: 17250681
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent.
Caballero-Florán RN; Conde-Rojas I; Oviedo Chávez A; Cortes-Calleja H; Lopez-Santiago LF; Isom LL; Aceves J; Erlij D; Florán B
Neuropharmacology; 2016 Nov; 110(Pt A):407-418. PubMed ID: 27506997
[TBL] [Abstract][Full Text] [Related]
17. H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release.
Chen BT; Avshalumov MV; Rice ME
J Neurophysiol; 2001 Jun; 85(6):2468-76. PubMed ID: 11387393
[TBL] [Abstract][Full Text] [Related]
18. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
[TBL] [Abstract][Full Text] [Related]
19. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
Castelli M; Federici M; Rossi S; De Chiara V; Napolitano F; Studer V; Motta C; Sacchetti L; Romano R; Musella A; Bernardi G; Siracusano A; Gu HH; Mercuri NB; Usiello A; Centonze D
Eur J Neurosci; 2011 Nov; 34(9):1369-77. PubMed ID: 22034972
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
Cragg S; Rice ME; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
